Name
Osaühing Laadi&Kõrgesaar
Registry code
11202866
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.01.2006 (18)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
549 850 €
38 369 €
7%
2 920 €
(estimate is approximate)
56 785 €
6
Submitted
No tax arrears
68%
41%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tatjana Laadi 26.05.1963 (61) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Karin Kõrgesaar 23.07.1969 (55) | - | Board member | - | Founder |
| 2019 28.06.2020 | 2020 29.06.2021 | 2021 29.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 234 500 € | 267 132 € | 340 282 € | 425 137 € | 549 850 € |
| Net profit (loss) for the period | 4 365 € | 16 652 € | 197 € | -2 371 € | 38 369 € |
| Profit Margin | 2% | 6% | 0% | -1% | 7% |
| Current Assets | 20 205 € | 38 269 € | 42 715 € | 40 789 € | 86 111 € |
| Fixed Assets | 5 890 € | 5 997 € | 5 050 € | 7 455 € | 6 913 € |
| Total Assets | 26 095 € | 44 266 € | 47 765 € | 48 244 € | 93 024 € |
| Current Liabilities | 14 580 € | 17 699 € | 23 012 € | 27 828 € | 36 239 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 11 515 € | 26 567 € | 24 753 € | 20 416 € | 56 785 € |
| Employees | 4 | 4 | 5 | 6 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 26 943.83 € | 28 823.03 € | 7 |
| 2023 Q4 | - | 24 268.62 € | 25 600.25 € | 7 |
| 2023 Q3 | - | 30 731.81 € | 32 337.56 € | 8 |
| 2023 Q2 | - | 24 343.56 € | 25 877.47 € | 8 |
| 2023 Q1 | - | 27 980.88 € | 29 725.91 € | 8 |
| 2022 Q4 | - | 20 135.93 € | 21 317.86 € | 8 |
| 2022 Q3 | - | 27 917.73 € | 29 332.48 € | 8 |
| 2022 Q2 | - | 21 072.28 € | 22 395.75 € | 9 |
| 2022 Q1 | - | 26 525.86 € | 28 373.55 € | 8 |
| 2021 Q4 | - | 18 628.84 € | 20 015.2 € | 7 |
| 2021 Q3 | - | 22 343.26 € | 23 580.47 € | 7 |
| 2021 Q2 | - | 16 058.59 € | 17 192.76 € | 7 |
| 2021 Q1 | - | 18 793.69 € | 20 154.6 € | 7 |
| 2020 Q4 | - | 14 152.44 € | 15 120.65 € | 7 |
| 2020 Q3 | - | 15 901.27 € | 16 621.14 € | 7 |
| 2020 Q2 | - | 12 418.44 € | 13 253.72 € | 6 |
| 2020 Q1 | - | 14 622.34 € | 15 637.17 € | 6 |
